Diverging Q3 2026: Herbalife Extends Growth Streak as Nu Skin and Medifast Contract
Third-quarter 2026 results split the direct selling sector into two camps, with Herbalife posting its fifth consecutive quarter of year-over-year revenue growth while Nu Skin and Medifast reported double-digit declines. The contrast extends to full-year guidance, where one company raised its outlook and the others braced for further contraction.

Herbalife posts fifth straight quarter of growth
Herbalife reported net sales of $1.35 billion for the third quarter of 2026, up 6.0% year over year, or 7.6% in constant currency. The result marked the company's fifth consecutive quarter of year-over-year revenue growth.
North America, long a watch point for the sector, grew 1.7% in the quarter β the region's second consecutive quarter of expansion.
On the bottom line, Herbalife posted net income of $58.8 million, diluted earnings per share of $0.55 and adjusted EPS of $0.64. Adjusted EBITDA came in at approximately $182 million, with the margin widening to 13.5%.
For the full 2026 financial year, the company is reported to expect revenue growth of between 4.9% and 5.9%, an upward revision from its original expectations.
Nu Skin's core business under pressure as Rhyz expands
Nu Skin Enterprises reported third-quarter revenue of $311.0 million, a 14.6% decline from $364.2 million in 2025. The pressure was concentrated in the core business, where revenue fell roughly 19.2%.
The company's Rhyz manufacturing segment moved in the opposite direction, growing 19.3% to $56.8 million. The customer base, however, contracted 18% compared with the prior year.
Quarterly results showed a GAAP loss of $0.02 per share, with adjusted earnings of $0.10 per share, against a $0.34 profit a year earlier. For full-year 2026, Nu Skin expects revenue of $1.26β1.29 billion, equivalent to an annual decline of 13β15%.
Medifast: fewer coaches, higher revenue per coach
Medifast reported third-quarter revenue of $72.0 million, down 19.4% from $89.4 million in 2025, and a net loss of $17.5 million. Gross profit fell 19.5% to $50 million on lower sales volume.
The number of active, earning coaches dropped to 10,200 from 19,500 a year earlier. Revenue per active coach rose 54.1% year over year to $7,064, partly offsetting the decline in the field headcount.
Despite the year-over-year drop, Medifast's revenue has now stabilised around the $75 million mark for a fourth consecutive quarter. The company guides to full-year 2026 revenue of $280β300 million and a loss per share of $1.80β2.05.
A two-speed sector
The broader industry picture for the third quarter shows several large players, including USANA, continuing to report declining revenue, while Herbalife registered expansion.
Taken together, the quarter underlines a widening gap between companies that have returned to top-line growth and those still working through contracting customer and distributor bases.
![[uk-house-ad] webinar4me banner 970Γ90](/_next/image?url=%2Fapi%2Fmedia%2Ffile%2Fuk-webinar4me-970x90.png&w=3840&q=75)
![[uk-house-ad] MLM System banner 970Γ90](/_next/image?url=%2Fapi%2Fmedia%2Ffile%2Fuk-mlmsystem-970x90.png&w=3840&q=75)

![[uk-house-ad] webinar4me banner 728Γ90](/_next/image?url=%2Fapi%2Fmedia%2Ffile%2Fuk-webinar4me-728x90.png&w=3840&q=75)
![[uk-house-ad] MLM System banner 728Γ90](/_next/image?url=%2Fapi%2Fmedia%2Ffile%2Fuk-mlmsystem-728x90.png&w=3840&q=75)

